Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.

Also called NCT01475552

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 130 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01475552
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01475552. Randomized; single masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2011-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Tailored Antiplatelet Therapy During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
Condition
Diabetes Mellitus
Intervention (Drug)
Abciximab
Intervention (Drug)
control
Lead sponsor
Seoul National University Bundang Hospital (class: other)

Record details

Record id
cardio:ct-nct01475552
Content hash
d9eb963c5418e530ad0c22575401403e1fcc146213b982bd8df0cfa933ca348c